The team at Phorum.AI is composed of distinguished professionals with an impressive pedigree from institutions such as MIT and Harvard. As pioneers in their field, they have a track record of creating new categories and driving innovation.
Collectively, they have successfully navigated multiple startup exits and hold over 125 patents, underscoring their expertise and leadership in both chemistry and AI development.
DAVID SHRIER
/ COFOUNDER / CHIEF EXECUTIVE OFFICER
BRAD PENTELUTE, PHD
/ COFOUNDER / CHIEF SCIENTIST
SOLI ZADEH
/ HEAD OF OPERATIONS
DAN CHINNAPEN, PHD
/ CHIEF SCIENTIFIC OFFICER
PRAVEEN MANDAL
/ CHIEF TECHNICAL OFFICER
ADELE JASHARI
/ HEAD OF BUSINESS STRATEGY
TOM GARDNER
RAJNI ANEJA
GRAHAM ANDERSON
DAVID KLEIN, PHD
At Phorum.AI, our mission is to transform biomanufacturing with advanced AI technologies, enabling more efficient, cost-effective, and scalable production processes
Brad Pentelute and David Shrier began developing Phorum in 2023 because they felt there was an opportunity to dramatically accelerate time to market for essential therapies through the evolution of computational chemistry, the application of AI systems to improving chemical processes. Critical bottlenecks in the production of life-saving treatments could be addressed much more rapidly and with greater success than before.
Applying decades of work on lab automation and model development, they assembled a world-class team and have placed Phorum.AI on an accelerated launch trajectory, signing our first customer of scale within 5 months of incorporation.
Phorum.AI is looking for change-makers to join our journey in producing advanced therapeutics at lower cost, greater speed, and with greater quality.
